Viruses within the Flaviviridae decrease CD4 expression and inhibit HIV replication in human CD4+ cells

Journal of Immunology

Volumn 183, Issue 12, 2009, Pages 7860-7869

  Xiang, Jinhua ^a   McLinden, James H ^a   Rydze, Robert A ^a   Chang, Qing ^a   Kaufman, Thomas M ^a   Klinzman, Donna ^a   Stapleton, Jack T ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; MESSENGER RNA; NONSTRUCTURAL PROTEIN 5; NONSTRUCTURAL PHOSPHOPROTEIN 5A, GB VIRUS TYPE C; PHOSPHOPROTEIN; VIRUS PROTEIN;

ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CELL SURFACE; CONTROLLED STUDY; DENGUE VIRUS; GENE EXPRESSION; HEPATITIS C VIRUS; HEPATITIS G VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; MACROPHAGE; PRIORITY JOURNAL; VIRUS REPLICATION; WEST NILE FLAVIVIRUS; YELLOW FEVER FLAVIVIRUS; BIOSYNTHESIS; DOWN REGULATION; FLAVIVIRIDAE INFECTION; GROWTH, DEVELOPMENT AND AGING; HOMEOSTASIS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; LEUKEMIA CELL LINE; METABOLISM; PHYSIOLOGY; VIROLOGY; VIRUS HEPATITIS;

ANTIGENS, CD4; CD4-POSITIVE T-LYMPHOCYTES; DOWN-REGULATION; FLAVIVIRIDAE INFECTIONS; GB VIRUS C; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HIV-1; HOMEOSTASIS; HUMANS; JURKAT CELLS; PHOSPHOPROTEINS; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 76249111370     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902276     Document Type: Article

References (56)

1. Calisher, C. H., and E. A. Gould. 2003. Taxonomy of the virus family Flaviviridae. Adv. Virus Res. 59: 1-19.
2. Lindenbach, B. D., and C. M. Rice. 2003. Molecular biology of flaviviruses. Adv. Virus Res. 59: 23-61.
3. Stapleton, J. T. 2003. GB virus type C/hepatitis G virus. Semin. Liver Dis. 23: 137-148.
4. Moradpour, D., F. Penin, and C. M. Rice. 2007. Replication of hepatitis C virus. Nat. Rev. Mircrobiol. 5: 453-463.
5. Macdonald, A., and M. Harris. 2004. Hepatitis C virus NS5A: tales of a promiscuous protein. J. Gen. Virol. 85: 2485-2502. (Pubitemid 39214345)
6. Alter, H. J. 1997. G-pers creepers, where'd you get those papers? A reassessment of the literature on the hepatitis G virus. Transfusion 37: 569-572.
7. Heringlake, S., J. Ockenga, H. L. Tillmann, C. Trautwein, D. Meissner, M. Stoll, J. Hunt, C. Jou, N. Solomon, R. E. Schmidt, and M. P. Manns. 1998. GB Virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients? J. Infect. Dis. 177: 1723-1726.
8. Toyoda, H., Y. Fukuda, T. Hayakawa, J. Takamatsu, and H. Saito. 1998. Effect of GB virus C/hepatitis G virus coinfection on the course of HIV infection in hemophilia patients in Japan. J. Acquir. Immune Defic. Syndr. 17: 209-213.
9. Tillmann, H. L., H. Heiken, A. Knapik-Botor, S. Heringlake, J. Ockenga, J. C. Wilber, B. Goergen, J. Detmer, M. P. Manns, M. Stoll, R. E. Schmidt, and M. P. Manns. 2001. Infection with GB virus C and reduced mortality among HIV-infected patients. N. Engl. J. Med. 345: 715-724.
10. Xiang, J., S. Wunschmann, D. J. Diekema, D. Klinzman, K. D. Patrick, S. L. George, and J. T. Stapleton. 2001. Effect of coinfection with GB Virus C (hepatitis G virus) on survival among patients with HIV infection. N. Engl. J. Med. 345: 707-714.
11. Williams, C. F., D. Klinzman, T. E. Yamashita, J. Xiang, P. M. Polgreen, C. Rinaldo, C. Liu, J. Phair, J. B. Margolick, D. Zdunek, G. Hess, and J. T. Stapleton. 2004. Persistent GB virus C infection and survival in HIV-infected men. N. Engl. J. Med. 350: 981-990.
12. Van der Bij, A. K., N. Kloosterboer, M. Prins, B. Boeser-Nunnink, R. B. Geskus, J. M. A. Lange, R. A. Coutinho, and H. Schuitemaker. 2005. GB Virus C coinfection and HIV-1 disease progression: The Amsterdam cohort study. J. Infect. Dis. 191: 678-685. (Pubitemid 40271054)
13. Zhang, W., K. Chaloner, H. L. Tillmann, C. F. Williams, and J. T. Stapleton. 2006. Effect of early and late GBV-C viremia on survival of HIV infected individuals: A meta-analysis. HIV Med. 7: 173-180.
14. Fogeda, M., S. Navas, J. Martin, M. Casqueiro, E. Rodriguez, C. Arocena, and V. Carreno. 1999. In vitro infection of human peripheral blood mononuclear cells by GB virus C/hepatitis G virus. J. Virol. 73: 4052-4061. (Pubitemid 29189850)
15. Xiang, J., S. Wunschmann, W. N. Schmidt, J. Shao, and J. T. Stapleton. 2000. Full-length GB virus C (hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells. J. Virol. 74: 9125-9133.
16. George, S. L., D. Varmaz, and J. T. Stapleton. 2006. GB virus C replicates in primary T and B lymphocytes. J. Infect. Dis. 193: 451-454.
17. Xiang, J., S. L. George, S. Wunschmann, Q. Chang, D. Klinzman, and J. T. Stapleton. 2004. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1α, MIP-1β, and SDF-1. Lancet 363: 2040-2046.
18. Jung, S., O. Knauer, N. Donhauser, M. Eichenmuller, M. Helm, B. Fleckenstein, and H. Reil. 2005. Inhibition of HIV strains by GB virus C in cell culture can be mediated by CD4 and CD8 T-lymphocyte derived soluble factors. AIDS 19: 1267-1272. (Pubitemid 41224895)
19. Xiang, J., M. A. Sathar, J. H. McLinden, D. Klinzman, Q. Chang, and J. T. Stapleton. 2005. South African GB virus C isolates: interactions between genotypes 1 and 5 GBV-C isolates and the human immunodeficiency virus. J. Infect. Dis. 192: 2147-2151.
20. Watt, G., P. Kantipong, and K. Jongsakul. 2003. Decrease in human immunodeficiency virus type 1 load during acute dengue fever. Clin. Infect. Dis. 36: 1067-1069. (Pubitemid 36513294)
21. Nattermann, J., H. D. Nischalke, B. Kupfer, J. Rockstroh, L. Hess, T. Sauerbruch, and U. Spengler. 2003. Regulation of CC chemokine receptor 5 in hepatitis G virus infection. AIDS 17: 1457-1462. (Pubitemid 36900546)
22. Jung, S., M. Eichenmueller, N. Donhauser, F. Neipel, A. M. Engel, G. Hess, B. Fleckenstein, and H. Reil. 2007. HIV entry inhibition by the envelope 2 glycoprotein of GB virus C. AIDS 21: 645-647. (Pubitemid 46303659)
23. + Jurkat T-cells. Proc. Natl. Acad. Sci. USA 103: 15570-15575.
24. + T-lymphocytes. J. Gen. Virol. 88: 3341-3346.
25. Xiang, J., J. H. McLinden, Q. Chang, E. L. Jordan, and J. T. Stapleton. 2008. Characterization of a peptide domain within the GB virus C NS5A phosphoprotein that inhibits HIV replication. PLoS One 3: e2580.
26. + T cell line inhibits HIV replication. J. Infect. Dis. 198: 860-863.
27. Xiang, J., C. Martinez-Smith, M. Jr. Gale, D. R. LaBrecque, W. N. Schmidt, and J. T. Stapleton. 2005. GB virus C NS5A sequence polymorphisms: association with interferon susceptibility and inhibition of PKR-mediated eIF-2α phosphorylation. J. Interferon Cytokine Res. 25: 261-270.
28. Schelsinger, L. S., S. R. Hurr, and T. M. Kaufman. 1994. Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. J. Immunol. 152: 4070-4079.
29. Sakata, H., M. Hishiyama, and A. Sugiura. 1984. Enzyme-linked immunosorbent assay compared with neutralization tests for evaluation of live mumps vaccines. J. Clin. Microbiol. 19: 21-25.
30. Litwin, J. 1964. Growth of 17D yellow fever virus and factors influencing its transmission within cell cultures in vitro. Acta Pathol. Microbiol. Scand. 61: 605-618.
31. Cook, R. T., J. T. Stapleton, D. Klinzman, and Z. K. Ballas. 1997. Effect of a single ethanol ingestion on lymphocyte subsets and in vitro HIV replication. J. Invest. Med. 45: 265-271.
32. Kumar, S., D. Tan, and M. Nei. 2004. MEGA3: Integrated software for molecular evolutionary genetics analysis and sequence alignment. Briefings Bioinform. 5: 150-163.
33. Koonin, E. V. 1991. The phylogeny of RNA-dependent RNA polymerases of positive-strand RNA viruses. J. Gen. Virol. 72: 2197-2206.
34. Yu, Y., A. J. Annala, J. R. Barrios, T. Toyokuni, N. Satyamurthy, M. Namavari, S. R. Cherry, M. E. Phelps, H. R. Herschman, and S. S. Gambhir. 2008. Quantification of target gene expression by imaging reporter gene expression in living animals. Nat. Med. 6: 933-937.
35. Tellinghuisen, T. L., J. Marcotrigiano, A. E. Gorbalenya, and C. M. Rice. 2004. The NS5A protein of hepatitis C virus is a zinc metalloprotein. J. Biol. Chem. 279: 48576-48687.
36. Gartner, S., P. Markovits, D. M. Markovits, M. H. Kaplan, R. C. Gallo, and M. Popovic. 1986. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233: 215-219.
37. c/ (RAG-hu) mouse model. Retrovirology 3: 76.
38. Blackley, S., Z. Kou, H. Chen, M. Quinn, R. C. Rose, J. J. Schlesinger, M. Coppage, and X. Jin. 2007. Primary human splenic macrophages, but not T or B cells, are the principal target cells for dengue virus infection in vitro. J. Virol. 81: 13325-13334.
39. Rios, M., M. J. Zhang, A. Grinev, K. Srinivasan, D. Daniel, O. Wood, I. K. Hewlett, and A. I. Dayton. 2006. Monocytes-macrophages are a potential target in human infection with West Nile virus through blood transfusion. Transfusion 46: 659-667.
40. Laskus, T., M. Radkowski, J. Jablonska, K. Kibler, J. Wilkinson, D. Adair, and J. Rakela. 2004. Human immunodeficiency virus facilitates infection/replication of hepatitis C virus in native human macrophages. Blood 103: 3854-3859. (Pubitemid 38596305)
41. Mentor, N. A., and I. Kurane. 1997. Dengue virus infection of human T lymphocytes. Acta Virol. 41: 175-176.
42. Denman, A. M., B. Rager-Zisman, T. C. Merigan, and D. A. Tyrell. 1974. Replication or inactivation of different viruses by human lymphocyte preparations. Infect. Immun. 9: 373-376.
43. Garcia-Tapia, D., C. M. Loiacono, and S. B. Kleiboeker. 2006. Replication of West Nile virus in equine peripheral blood mononuclear cells. Vet. Immunol. Immunopathol. 110: 229-244.
44. Laskus, T., M. Radkowski, L. F. Wang, S. J. Jang, H. Vargas, and J. Rakela. 1998. Hepatitis C virus quasispecies in patients infected with HIV-1: correlation with extrahepatic replication. Virology 248: 164-171.
45. Kondo, Y., V. M. Sung, K. Machida, M. Liu, and M. M. Lai. 2007. Hepatitis C virus infects T cells and affects interferon-γ signaling in T cell lines. Virology 361: 161-173.
46. Lin, Y. W., K. J. Wang, H. Y. Lei, Y. S. Lin, T. M. Yeh, H. S. Liu, C. C. Liu, and S. H. Chen. 2002. Virus replication and cytokine production in dengue virus-infected human B lymphocytes. J. Virol. 76: 12242-12249.
47. Schlesinger, J. J., and M. W. Brandriss. 1981. Antibody-mediated infection of macrophages and macrophage-like cell lines with 17D-yellow fever virus. J. Med. Virol. 8: 103-117.
48. Miceli, M. C., and J. R. Parnes. 1993. Role of CD4 and CD8 in T cell activation and differentiation. Adv. Immunol. 53: 59-122.
49. Dalgleish, A. G., P. C. L. Beverley, P. R. Clapham, D. H. Crawford, M. F. Greaves, and R. A. Weiss. 1984. The CD4 (T4) antigen is an essential component of the receptor for human retrovirus LAV. Nature 312: 763-767.
50. Bowers, K., C. Pitcher, and M. Marsh. 1997. CD4: a coreceptor in the immune response and HIV infection. Int. J. Biochem. Cell Biol. 29: 871-875.
51. Douek, D. C. 2003. Disrupting T-cell homeostasis: how HIV-1 infection causes disease. AIDS Rev. 5: 172-177.
52. Douek, D. C. 2007. HIV disease progression: immune activation, microbes, and a leaky gut. Top. HIV Med. 15: 114-117.
53. Stapleton, J. T., K. Chaloner, J. Zhang, D. Klinzman, I. E. Souza, J. Xiang, A. Landay, J. Fahey, R. Pollard, and R. Mitsuyasu. 2008. GB virus C viremia is associated with reduced CD4 expansion following interleukin 2 therapy in HIV-infected people receiving HAART. AIDS 23: 605-610.
54. Hoxie, J. A., J. D. Alpers, J. L. Rackowski, K. Huebner, B. S. Haggarty, A. J. Cedarbaum, and J. C. Reed. 1986. Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV. Science 234: 1123-1127.
55. Lisco, A., J. C. Grivel, A. Biancotto, C. Vanpoulle, F. Origgi, M. S. Malnati, D. Schols, P. Lusso, and L. B. Margolis. 2007. Viral interactions in human lymphoid tissue: human herpesvirus 7 suppresses the replication of CCR5-tropic human immunodeficiency virus type 1 via CD4 modulation. J. Virol. 81: 708-717.
56. + T lymphocytes. Virology 69: 5243-5251.